Global Aspiration & Biopsy Needles Market Size Study & Forecast, by Product (Aspiration Needle, CNB, VAB), Application (Breast, Lung, Bone Cancer), Procedure (Image-guided (Ultrasound, MRI, Stereotactic), Non-image-guided), End User (Hospital, ASC, Academ

The Global Aspiration & Biopsy Needles Market, valued at approximately USD 1.06 billion in 2024, is projected to grow at a remarkable CAGR of 6.80% from 2025 to 2035. Aspiration and biopsy needles play a critical role in modern diagnostic medicine, enabling physicians to accurately retrieve tissue or fluid samples for histopathological examination. These devices are indispensable in detecting malignancies, staging cancer, and guiding treatment plans across a variety of anatomical sites. The rising global cancer burden, coupled with increasing awareness about the importance of early detection, is propelling the adoption of these minimally invasive diagnostic tools. Advancements in needle design, such as improved tip sharpness, ergonomic handling, and enhanced compatibility with imaging modalities, are further transforming procedural accuracy and patient comfort. This technological momentum, combined with growing investments in precision diagnostics, continues to reinforce market expansion.

The surging demand for minimally invasive procedures has catalyzed the growth of aspiration and biopsy needle usage in oncology, pulmonology, and orthopedics. With the World Health Organization estimating that cancer cases will surge by nearly 47% over the next two decades, healthcare systems are prioritizing early and accurate diagnosis. Image-guided biopsy procedures—leveraging ultrasound, MRI, and stereotactic systems—are gaining traction due to their superior accuracy in targeting lesions, reducing the need for repeat interventions. Simultaneously, academic research and clinical trials are driving demand for specialized biopsy instruments, offering a lucrative pathway for product innovation. However, factors such as procedural risks, infection concerns, and the availability of alternative diagnostic methods may restrain growth in certain segments. Yet, continuous R&D efforts and the increasing integration of artificial intelligence in diagnostic imaging are expected to counter these challenges, unlocking new revenue streams over the forecast period.

Geographically, North America dominated the market in 2024, attributed to its advanced healthcare infrastructure, high diagnostic imaging penetration, and favorable reimbursement frameworks for cancer screening and biopsy procedures. The United States, in particular, benefits from a well-established oncology ecosystem and a strong presence of leading medical device manufacturers. Europe follows closely, bolstered by rising cancer incidence, public health screening programs, and stringent quality standards that encourage the adoption of high-performance biopsy systems. The Asia Pacific region is anticipated to witness the fastest growth between 2025 and 2035, fueled by escalating healthcare investments, expanding hospital networks, and government-led cancer screening initiatives in countries like China and India. Additionally, growing medical tourism, rapid urbanization, and an increasing pool of trained interventional radiologists are enhancing procedural volumes in the region. Emerging markets in Latin America and the Middle East & Africa are also showing promising uptake, driven by gradual improvements in diagnostic infrastructure and increasing awareness of preventive healthcare.

Major market player included in this report are:
• Medtronic plc
• Becton, Dickinson and Company (BD)
• Hologic, Inc.
• Boston Scientific Corporation
• Cook Medical LLC
• Olympus Corporation
• Argon Medical Devices, Inc.
• Stryker Corporation
• B. Braun Melsungen AG
• Cardinal Health, Inc.
• INRAD Inc.
• INRAD Medical Systems
• ConMed Corporation
• Integra LifeSciences Holdings Corporation
• Merit Medical Systems, Inc.

Global Aspiration & Biopsy Needles Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period – 2025-2035
• Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa



The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Product:
• Aspiration Needle
• CNB
• VAB

By Application:
• Breast Cancer
• Lung Cancer
• Bone Cancer

By Procedure:
• Image-guided

o Ultrasound

o MRI

o Stereotactic
• Non-image-guided

By End User:
• Hospital
• ASC
• Academia

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more